These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition. Borczuk A; Mannion C; Dickson D; Alt E Mod Pathol; 1995 Jun; 8(5):577-82. PubMed ID: 7675780 [TBL] [Abstract][Full Text] [Related]
5. Beta 2-microglobulin amyloidosis presenting as esophageal perforation in a hemodialysis patient. Khan GA; Lewis FI; Dasgupta M Am J Nephrol; 1997; 17(6):524-7. PubMed ID: 9426849 [TBL] [Abstract][Full Text] [Related]
7. Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis. Fernández-Alonso J; Rios-Camacho C; Valenzuela-Castaño A; Rocha-Castilla JL J Clin Pathol; 1993 Aug; 46(8):771-2. PubMed ID: 8408708 [TBL] [Abstract][Full Text] [Related]
8. Pleural involvement of dialysis-related amyloidosis. Suzuki M; Betsuyaku T; Kojima T; Saito H; Nishiura Y; Fukasawa Y; Nishimura M; Kawakami Y Intern Med; 2005 Jun; 44(6):628-31. PubMed ID: 16020894 [TBL] [Abstract][Full Text] [Related]
9. Unresolved lytic lesions following parathyroidectomy in a patient with chronic renal failure. Fok WM; Leung HB J Bone Joint Surg Br; 2008 Apr; 90(4):506-9. PubMed ID: 18378929 [TBL] [Abstract][Full Text] [Related]
10. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy]. Czyz W; Szepietowski T Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582 [TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration. Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678 [TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of amyloidosis: a role for anti-proteases?]. Argilés i Ciscart A; Mourad G Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439 [TBL] [Abstract][Full Text] [Related]
13. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients. Saito A; Gejyo F Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183 [TBL] [Abstract][Full Text] [Related]
16. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure. Miyata T Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient. Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922 [TBL] [Abstract][Full Text] [Related]
18. The Case | A hip fracture in a hemodialysis patient. Pathologic right-hip fracture from β2-microglobulin amyloidosis. Bataille S; Fernandez C; Zink JV; Brunet P; Berland Y; Burtey S Kidney Int; 2013 Jun; 83(6):1211-2. PubMed ID: 23728017 [No Abstract] [Full Text] [Related]
19. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient. Kanai H; Kashiwagi M; Hirakata H; Nagashima A; Tada S; Yao T; Nakamoto M; Nakamura S; Fujishima M Clin Nephrol; 2000 May; 53(5):394-9. PubMed ID: 11305814 [TBL] [Abstract][Full Text] [Related]